Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous conditioned serum for chronic knee osteoarthritis
IRCT20160422027520N13Phase 2Completed
- Sponsor
- Pishtaz Teb Zaman
- Start
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous conditioned serum in knee osteoarthritis (OA) (2 arms), sponsored by Pishtaz Teb Zaman. Primary endpoints: Knee pain by Visual Analog Scale, Knee function by WOMAC and 2 more. Started Aug 2019; status: completed.
02
Drugs
autologous conditioned serum
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20160422027520N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160422027520N13.